subject area of
- Activity of fulvestrant in HER2-overexpressing advanced breast cancer Academic Article
- Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer Academic Article
- Functional characterization of estrogen receptor subtypes, ERα and ERβ, mediating vitellogenin production in the liver of rainbow trout Academic Article
- Non-genomic action of estradiol and progesterone on cytosolic calcium concentrations in primary cultures of human granulosa-lutein cells Academic Article
- Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer Academic Article
- Presence and bioavailability of bisphenol A in the uterus of rats and mice following single and repeated dietary administration at low doses Academic Article
- Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study Academic Article
- Rapid action of pesticides on cytosolic calcium concentrations in cultures of human umbilical vein endothelial cells Academic Article
- Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2) Academic Article